Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Background —Tumor necrosis factor-α (TNF-α) is a multifunctional cytokine that has been detected in several human cardiac-related conditions, including congestive heart failure and septic cardiomyopathy. In these conditions, the origin of TNF-α secretion is, at least in part, cardiac myocytes. Methods and Results —To determine the consequences of TNF-α production by cardiac myocytes in vivo, we developed transgenic mice in which expression of a murine TNF-α coding sequence was driven by the murine α-myosin heavy chain promoter. Four transgenic founders developed an identical illness consisting of tachypnea, decreased activity, and hunched posture. In vivo, ECG-gated MRI of symptomatic transgenic mice documented a severe impairment of cardiac function evidenced by biventricular dilatation and depressed ejection fractions. All transgenic mice died prematurely. Pathological examination of affected animals revealed a globular dilated heart, bilateral pleural effusions, myocyte apoptosis, and transmural myocarditis in both the right and left ventricular free walls, septum, and atrial chambers. In all terminally ill animals, there was significant biventricular fibrosis and atrial thrombosis. Conclusions —This is the first report detailing the effects of tissue-specific production of TNF-α by cardiac myocytes in vivo. These findings indicate that production of TNF-α by cardiac myocytes is sufficient to cause severe cardiac disease and support a causal role for this cytokine in the pathogenesis of human cardiac disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., & Cerami, A. (1986) · Science · doi:10.1126/science.3754653 · Cited by 1,268
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
Suffredini, A. F., Fromm, R. E., Parker, M. M., Brenner, M., Kovacs, J. A., Wesley, R. A., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,102
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Cited by
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., & Walsh, K. (2005) · Nature Medicine · doi:10.1038/nm1295 · Cited by 982
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Vasan, R. S., Sullivan, L. M., Roubenoff, R., Dinarello, C. A., Harris, T., Benjamin, E. J., Sawyer, D. B., Levy, D., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 746
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
Frantz, S., Kobzik, L., Kim, Y.-D., Fukazawa, R., Medzhitov, R., Lee, R. T., & Kelly, R. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6709 · Cited by 645
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Siwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
The role of tumor necrosis factor in the pathophysiology of heart failure
Feldman, A. M., Combes, A., Wagner, D., Kadakomi, T., Kubota, T., You Li, Y., & McTiernan, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00600-2 · Cited by 506
Inflammatory Markers and Incident Heart Failure Risk in Older Adults
Kalogeropoulos, A., Georgiopoulou, V., Psaty, B. M., Rodondi, N., Smith, A. L., Harrison, D. G., Liu, Y., Hoffmann, U., Bauer, D. C., Newman, A. B., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.045 · Cited by 478
Pathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
Kwon, H. J., Cot, T. R., Cuffe, M. S., Kramer, J. M., & Braun, M. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-10-200305200-00008 · Cited by 455
Congestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 437
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Kleinbongard, P., Heusch, G., & Schulz, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.002 · Cited by 409
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Zhang, H., & Dhalla, N. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021082 · Cited by 385
Sivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/hc3401.093154 · Cited by 382
Giordano, F. J., Gerber, H.-P., Williams, S.-P., VanBruggen, N., Bunting, S., Ruiz-Lozano, P., Gu, Y., Nath, A. K., Huang, Y., Hickey, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091415198 · Cited by 370
Role of apoptosis in cardiovascular disease
Lee, Y., & Gustafsson, Å. B. (2009) · Apoptosis · doi:10.1007/s10495-008-0302-x · Cited by 346
Post-infarct remodelling: contribution of wound healing and inflammation
Frantz, S., Bauersachs, J., & Ertl, G. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn292 · Cited by 287
Haudek, S. B., Taffet, G. E., Schneider, M. D., & Mann, D. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29134 · Cited by 278
Immune Activation in Chronic Heart Failure
Torre-Amione, G. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.006 · Cited by 272
Xia, Y., Lee, K., Li, N., Corbett, D., Mendoza, L., & Frangogiannis, N. G. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0541-5 · Cited by 264
Ohtsuka, T., Hamada, M., Hiasa, G., Sasaki, O., Suzuki, M., Hara, Y., Shigematsu, Y., & Hiwada, K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01121-9 · Cited by 253
MORI, R., KONDO, T., OHSHIMA, T., ISHIDA, Y., & MUKAIDA, N. (2002) · The FASEB Journal · doi:10.1096/fj.01-0776com · Cited by 250
MYOCARDIAL DYSFUNCTION IN SEPTIC SHOCK
Kumar, A., Haery, C., & Parrillo, J. E. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70110-x · Cited by 233
De Windt, L. J., Lim, H. W., Taigen, T., Wencker, D., Condorelli, G., Dorn, G. W., Kitsis, R. N., & Molkentin, J. D. (2000) · Circulation Research · doi:10.1161/01.res.86.3.255 · Cited by 225
Westermann, D., Linthout, S., Dhayat, S., Dhayat, N., Schmidt, A., Noutsias, M., Song, X.-Y., Spillmann, F., Riad, A., Schultheiss, H.-P., et al. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0673-0 · Cited by 207
The Role of Monocytes and Inflammation in the Pathophysiology of Heart Failure
Wrigley, B. J., Lip, G. Y. H., & Shantsila, E. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr122 · Cited by 200
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00594-x · Cited by 196
Organ crosstalk: the role of the kidney
Li, X., Hassoun, H. T., Santora, R., & Rabb, H. (2009) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328332f69e · Cited by 195
High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced Apoptosis
Sugano, M., Tsuchida, K., & Makino, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2877 · Cited by 181
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
Stypmann, J., Gläser, K., Roth, W., Tobin, D. J., Petermann, I., Matthias, R., Mönnig, G., Haverkamp, W., Breithardt, G., Schmahl, W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092637699 · Cited by 179
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
Baik, A. H., Oluwole, O. O., Johnson, D. B., Shah, N., Salem, J.-E., Tsai, K. K., & Moslehi, J. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.315894 · Cited by 138
PORTER, K., TURNER, N., OREGAN, D., & BALL, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.020 · Cited by 123
Elliott, J. F., Liu, J., Yuan, Z.-N., Bautista-Lopez, N., Wallbank, S. L., Suzuki, K., Rayner, D., Nation, P., Robertson, M. A., Liu, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235552100 · Cited by 80
La Gerche, A., Inder, W. J., Roberts, T. J., Brosnan, M. J., Heidbuchel, H., & Prior, D. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130031 · Cited by 80
Impaired Exercise Capacity and Skeletal Muscle Function in a Mouse Model of Pulmonary Inflammation
Tang, K., Murano, G., Wagner, H., Nogueira, L., Wagner, P. D., Tang, A., Dalton, N. D., Gu, Y., Peterson, K. L., & Breen, E. C. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00607.2012 · Cited by 30
The role of inflammation in the pathogenesis of heart failure
Lisman, K. A., Stetson, S. J., Koerner, M. M., Farmer, J. A., & Torre-Amione, G. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0051-3 · Cited by 18
Metadata
- Authors
- Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B.
- Venue
- Circulation
- Published
- 1998-04-14
- Volume
- 97
- Issue
- 14
- Pages
- 1375-1381
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2007754282
- Cited by
- 600
- References
- 49
- FWCI
- 30.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.